author-photo

Kirsten L. Morton

Johnson & Johnson Pharmaceutical Research and Development

9

Papers

276

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Novel Benzamide-Based Histamine H3 Receptor Antagonists: The Identification of Two Candidates for Clinical Development

2015 ACS Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (11)
Synthesis and Pharmacological Characterization of Two Novel, Brain Penetrating P2X7 Antagonists

2013 ACS Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (35)
Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement

2011 Psychopharmacology
Show All
- Source
- Cite
- Save
Citations (120)
The discovery and synthesis of JNJ 31020028, a small molecule antagonist of the Neuropeptide Y Y2 receptor

2011 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (12)
Indole- and benzothiophene-based histamine H3 antagonists.

2010 Bioorganic & Medicinal Chemistry Letters
Show All
- Source
- Cite
- Save
Citations (11)
In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y2 receptor

2010 Psychopharmacology
Show All
- Source
- Cite
- Save
Citations (38)
Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists

2009 European Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (20)